2 ML lanadelumab-flyo 150 MG/ML Injection

RxNorm concept 2055645, clinical drug (scd). Prescribable name: lanadelumab-flyo 300 MG in 2 ML Injection.

RxCUI: 2055645
Term type: Clinical drug (SCD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2055645 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

lanadelumab 2055641

Other names

lanadelumab-flyo 300 MG per 2 ML Injection

Related concepts

lanadelumab-flyo 150 MG/ML (SCDC, consists of)
Injection (DF, has dose form)
2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] (SBD, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2055645 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2055645 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2055645. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.